Grant Private Wealth Management Inc acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,850 shares of the medical research company's stock, valued at approximately $383,000.
Several other large investors have also recently added to or reduced their stakes in the business. CKW Financial Group grew its position in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. grew its holdings in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Lee Danner & Bass Inc. purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at approximately $29,000. Hanson & Doremus Investment Management raised its holdings in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after purchasing an additional 105 shares in the last quarter. Finally, OFI Invest Asset Management purchased a new stake in shares of Agilent Technologies during the 4th quarter worth $37,000.
Insider Activity at Agilent Technologies
In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares of the company's stock, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the transaction, the director now owns 35,737 shares of the company's stock, valued at $4,161,931.02. The trade was a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,638 shares of company stock worth $731,229 over the last 90 days.
Agilent Technologies Stock Performance
A traded up $0.40 during trading on Tuesday, hitting $103.99. The stock had a trading volume of 1,220,853 shares, compared to its average volume of 1,803,128. Agilent Technologies, Inc. has a twelve month low of $98.51 and a twelve month high of $155.35. The firm has a market capitalization of $29.65 billion, a P/E ratio of 23.91, a PEG ratio of 2.89 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company's 50-day moving average price is $129.40 and its 200 day moving average price is $135.44.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.95%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.
Analyst Upgrades and Downgrades
Several research firms recently commented on A. Citigroup increased their target price on Agilent Technologies to $165.00 and gave the company a "buy" rating in a report on Thursday, December 19th. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a research note on Monday, December 9th. Bank of America reduced their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Barclays raised shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Finally, StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $150.83.
Check Out Our Latest Stock Report on Agilent Technologies
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
